Patents by Inventor David Witcombe

David Witcombe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acids encoding a recombinant 250 kDa antigen from sporozoites/merozoites of and their uses
    Patent number: 7462707
    Abstract: The present invention provides an isolated nucleic acid comprising a nucleotide sequence encoding a 250 kDa polypeptide from Sporozoites/Merozoites of Eimeria maxima, or encoding a homolog of the polypeptide, or a complement of the nucleic acid and a method of producing a recombinant 250 kDa polypeptide of the same. The present invention also provides an isolated nucleic acid comprising a nucleotide sequence encoding an immunodominant portion of a 250 kDa polypeptide from Sporozoites/Merozoites of Eimeria maxima having the amino acid sequence described herein, or encoding a homolog of the polypeptide, or a complement of the nucleic acid.
    Type: Grant
    Filed: July 3, 2002
    Date of Patent: December 9, 2008
    Assignees: University of Technology, Sydney, Abic Biological Laboratories Teva, Ltd.
    Inventors: David Witcombe, Nicholas C. Smith, Michael Wallach